A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)
Public ClinicalTrials.gov record NCT01059630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter, Randomized, Phase III Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma
Study identification
- NCT ID
- NCT01059630
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Genentech, Inc.
- Industry
- Enrollment
- 413 participants
Conditions and interventions
Conditions
Interventions
- Obinutuzumab Drug
- Bendamustine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 29, 2010
- Primary completion
- Sep 29, 2014
- Completion
- Nov 29, 2018
- Last update posted
- Jan 12, 2020
2010 – 2018
United States locations
- U.S. sites
- 33
- U.S. states
- 21
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Cancer Center, PC | Mobile | Alabama | 36608 | — |
| Dr. Donald W. Hill, MD, FACP | Casa Grande | Arizona | 85122 | — |
| Highlands Oncology Group | Rogers | Arkansas | 72758 | — |
| Kaiser Permanente - Bellflower | Bellflower | California | 90706 | — |
| Bay Area Cancer Research Group, LLC | Pleasant Hill | California | 94523 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| Georgetown University Medical Center Lombardi Cancer Center | Washington D.C. | District of Columbia | 20007 | — |
| Washington DC VA Med Center; Hematology | Washington D.C. | District of Columbia | 20422 | — |
| University of Florida | Gainesville | Florida | 32607 | — |
| University of Florida; Division of Hematology/Oncology | Gainesville | Florida | 33610-0277 | — |
| Md Anderson Cancer Center Orlando | Orlando | Florida | 32806 | — |
| Rush Cancer Institute | Chicago | Illinois | 60612 | — |
| Quincy Medical Group | Quincy | Illinois | 62301 | — |
| Simmons Cancer Institute | Springfield | Illinois | 62794-9677 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Univ Louisville School of Med | Louisville | Kentucky | 40202 | — |
| New England Cancer Specialists | Scarborough | Maine | 04074 | — |
| Meritus Center for Clinical Research | Hagerstown | Maryland | 21740 | — |
| Capitol Comprehensive CA Care | Jefferson City | Missouri | 65101 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Hematology Oncology Assoc SJ | Mount Holly | New Jersey | 08060 | — |
| San Juan Oncology | Farmington | New Mexico | 87401 | — |
| The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. | Columbus | Ohio | 43219 | — |
| OHSU Knight Cancer Institute | Portland | Oregon | 97210 | — |
| Pacific Oncology, PC | Portland | Oregon | 97210 | — |
| OHSU Ctr for Health & Healing | Portland | Oregon | 97239 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| Sanford Health System | Sioux Falls | South Dakota | 57105 | — |
| South Texas Inst of Cancer | Corpus Christi | Texas | 78405 | — |
| University of Texas M.D. Anderson Cancer Center | Houston | Texas | 77030 | — |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109 | — |
| Univ of Wisconsin Hosp & Clin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 88 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01059630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01059630 live on ClinicalTrials.gov.